Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.

Hypoxia stimulates synovial hypoperfusion in rheumatoid arthritis (RA). TXNDC5 stimulates cellular proliferation in hypoxic conditions. We previously detected increased TXNDC5 expression in synovial tissues and blood from RA patients and demonstrated that the gene encoding TXNDC5 increased RA risk....

Full description

Bibliographic Details
Main Authors: Lin Wang, Yabing Zheng, Hengwei Xu, Xinfeng Yan, Xiaotian Chang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3541148?pdf=render
id doaj-fa986eaa94e44c07b1312a70908e3b00
record_format Article
spelling doaj-fa986eaa94e44c07b1312a70908e3b002020-11-25T00:03:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5330110.1371/journal.pone.0053301Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.Lin WangYabing ZhengHengwei XuXinfeng YanXiaotian ChangHypoxia stimulates synovial hypoperfusion in rheumatoid arthritis (RA). TXNDC5 stimulates cellular proliferation in hypoxic conditions. We previously detected increased TXNDC5 expression in synovial tissues and blood from RA patients and demonstrated that the gene encoding TXNDC5 increased RA risk. The present study investigated the pathogenic roles of TXNDC5 in RA. Transgenic mice that over-expressed TXNDC5 (TXNDC5-Tg) were generated using C57BL/6J mice and treated with bovine collagen II to induce arthritis (CIA). Synovial fibroblasts from RA patients (RASFs) were cultured and incubated with TXNDC5-siRNA or CoCl(2), a chemical that induces hypoxia. CIA was observed in 80% of the TXNDC5-Tg, but only 20% of the wild-type mice (WT) developed CIA. The clinical arthritis scores reached 5 in the TXNDC5-Tg, but this index only reached 2 in the control mice. CIA TXNDC5-Tg exhibited clear pannus proliferation and bone erosion in joint tissues. A significant increase in CD4 T cells was observed in the thymus and spleen of TXNDC5-Tg during CIA. Serum levels of anti-collagen II IgG, IgG1 and IgG2a antibodies were significantly elevated in the mice. Increased cell proliferation, cell migration and TXNDC5 expression were observed in RASFs following incubation with 1 µM CoCl(2). However, this effect was diminished when TXNDC5 expression was inhibited with 100 nM siRNA. TNF-alpha, IL-1α, IL-1β and IL-17 levels were significantly increased in the blood of TXNDC5-Tg mice, but the levels of these cytokines declined in the supernatant of RASFs that were treated with TXNDC5 siRNA. The expression of adiponectin, a cytokine-like mediator, decreased significantly in RASFs following TXNDC5 siRNA treatment. These results suggest that TXNDC5-over-expressing mice were susceptible to CIA. This study also suggests that hypoxia induced TXCNDC5 expression, which contributed to adiponectin expression, cytokine production and the cellular proliferation and migration of fibroblasts in RA.http://europepmc.org/articles/PMC3541148?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Lin Wang
Yabing Zheng
Hengwei Xu
Xinfeng Yan
Xiaotian Chang
spellingShingle Lin Wang
Yabing Zheng
Hengwei Xu
Xinfeng Yan
Xiaotian Chang
Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.
PLoS ONE
author_facet Lin Wang
Yabing Zheng
Hengwei Xu
Xinfeng Yan
Xiaotian Chang
author_sort Lin Wang
title Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.
title_short Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.
title_full Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.
title_fullStr Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.
title_full_unstemmed Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis.
title_sort investigate pathogenic mechanism of txndc5 in rheumatoid arthritis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Hypoxia stimulates synovial hypoperfusion in rheumatoid arthritis (RA). TXNDC5 stimulates cellular proliferation in hypoxic conditions. We previously detected increased TXNDC5 expression in synovial tissues and blood from RA patients and demonstrated that the gene encoding TXNDC5 increased RA risk. The present study investigated the pathogenic roles of TXNDC5 in RA. Transgenic mice that over-expressed TXNDC5 (TXNDC5-Tg) were generated using C57BL/6J mice and treated with bovine collagen II to induce arthritis (CIA). Synovial fibroblasts from RA patients (RASFs) were cultured and incubated with TXNDC5-siRNA or CoCl(2), a chemical that induces hypoxia. CIA was observed in 80% of the TXNDC5-Tg, but only 20% of the wild-type mice (WT) developed CIA. The clinical arthritis scores reached 5 in the TXNDC5-Tg, but this index only reached 2 in the control mice. CIA TXNDC5-Tg exhibited clear pannus proliferation and bone erosion in joint tissues. A significant increase in CD4 T cells was observed in the thymus and spleen of TXNDC5-Tg during CIA. Serum levels of anti-collagen II IgG, IgG1 and IgG2a antibodies were significantly elevated in the mice. Increased cell proliferation, cell migration and TXNDC5 expression were observed in RASFs following incubation with 1 µM CoCl(2). However, this effect was diminished when TXNDC5 expression was inhibited with 100 nM siRNA. TNF-alpha, IL-1α, IL-1β and IL-17 levels were significantly increased in the blood of TXNDC5-Tg mice, but the levels of these cytokines declined in the supernatant of RASFs that were treated with TXNDC5 siRNA. The expression of adiponectin, a cytokine-like mediator, decreased significantly in RASFs following TXNDC5 siRNA treatment. These results suggest that TXNDC5-over-expressing mice were susceptible to CIA. This study also suggests that hypoxia induced TXCNDC5 expression, which contributed to adiponectin expression, cytokine production and the cellular proliferation and migration of fibroblasts in RA.
url http://europepmc.org/articles/PMC3541148?pdf=render
work_keys_str_mv AT linwang investigatepathogenicmechanismoftxndc5inrheumatoidarthritis
AT yabingzheng investigatepathogenicmechanismoftxndc5inrheumatoidarthritis
AT hengweixu investigatepathogenicmechanismoftxndc5inrheumatoidarthritis
AT xinfengyan investigatepathogenicmechanismoftxndc5inrheumatoidarthritis
AT xiaotianchang investigatepathogenicmechanismoftxndc5inrheumatoidarthritis
_version_ 1725433804224462848